Advertisement

Spinal Tech

Analysts are predicting the orthopedic device market will experience low growth over the next few years, according to a Mass Device report.

After former CEO Stephen MacMillan resigned last week, Stryker announced the interim chief executive will receive a $750,000 annual salary, according to a Wall Street Journal report.

Advertisement

Zimmer and ISTO Technologies have announced a Phase III clinical study to evaluate DeNovo ET Engineered Tissue Graft, an engineered cartilage implant for repairing cartilage defects in the knee, according to a company news release.

Titan Spine recently acquired two patents related to surface modification techniques for its products, according to a company news release.

Amedica has launched an extension of its Valeo product line, the Valeo VBR, for increased fusion potential in corpectomy procedures, according to a company news release.

Advertisement